PRO17 Cost-Minimization Analysis of Lanreotide Autogel Versus Octreotide LAR in Patients with Acromegaly in the Brazilian Public Health System

Abstract

Authors

P. Serafini M. Suseda F. Ortis T. Mendanha

Full Text Cite This Article
Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×